Drug Shortage Report for ERYTHRO-BASE

Last updated on 2018-04-23 History
Report ID 30979
Drug Identification Number 00682020
Brand name ERYTHRO-BASE
Common or Proper name ERYTHRO-BASE
Company Name AA PHARMA INC
Active Ingredient(s) ERYTHROMYCIN
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-28
Estimated end date 2017-12-11
Actual end date 2017-12-12
Shortage status Resolved
Updated date 2018-04-23
Company comments
Health Canada comments
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-04-23 French Compare
v4 2018-04-23 English Compare
v3 2017-11-29 English Compare
v2 2017-11-28 French Compare
v1 2017-11-28 English Compare